This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Lung Cancer  • Pulmonary Diseases  • Pulmonary Diseases, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Mark B. Faries, MD; Richard J. Bleicher, MD; Xing Ye, MS; Richard Essner, MD; Donald L. Morton, MD

Arch Surg. 2004;139:870-877.

Background  Mediastinal lymph node sampling understages a significant number of lung cancers, even when nodes are evaluated by immunohistochemical techniques. Intraoperative lymphatic mapping and sentinel lymphadenectomy allows focused pathologic evaluation of a few lymph nodes that accurately stage the entire basin.

Hypothesis  Lymphatic mapping and sentinel lymphadenectomy is a practical and accurate method of staging lymph nodes that drain primary and metastatic neoplasms of the lung.

Design and Setting  Retrospective review at a tertiary referral center.

Patients  Sixty-seven patients undergoing resection of lung tumors.

Main Outcome Measures  Sentinel lymph node (SN) identification rate, number of SNs, nodal pathologic features, and survival.

Results  Twenty-eight patients had primary lung cancer and 39 had pulmonary metastases from melanoma (33 cases), squamous cell carcinoma (2 cases), colon cancer (2 cases), or other cancers (2 cases). Lymphatic mapping and sentinel lymphadenectomy was successful in all patients. The median number of lymph nodes identified by dye alone was 2 (range, 1-7); the median number identified by dye plus radiocolloid was 4 (range, 1-9). Most SNs (69%) were N1; 31% were N2. Lower lobe lesions drained to upper mediastinal nodes in 3 (13%) of 24 cases. Lymph node metastases were found in 11 patients with lung cancer (39%) and 8 patients with pulmonary metastases (21%). Ten (91%) of the 11 patients with lung cancer had SN involvement. In the 33 patients with metastatic melanoma, SN involvement significantly reduced the rate of 2-year survival (0% vs 48%).

Conclusions  Lymphatic mapping and sentinel lymphadenectomy of intrapulmonary malignancies is technically challenging but feasible. Blue dye is most useful for in vivo identification of SNs; ex vivo radioactivity can confirm that excised nodes are SNs. Lymphatic mapping and sentinel lymphadenectomy can provide important prognostic information for patients with melanoma and lung metastases, and it may improve the staging of primary lung cancer.

From the Roy E. Coats Research Laboratories, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, Calif.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnostic Surgical Pathology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Schwartz and Henson
Chest 2007;132:78S-93S.
ABSTRACT | FULL TEXT  

Prognostic role of lymph node involvement in lung metastasectomy
Veronesi et al.
J. Thorac. Cardiovasc. Surg. 2007;133:967-972.
ABSTRACT | FULL TEXT  

Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer
Nwogu et al.
Ann. Thorac. Surg. 2006;82:1815-1820.
ABSTRACT | FULL TEXT  

Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
Chen et al.
CA Cancer J Clin 2006;56:292-309.
ABSTRACT | FULL TEXT  

Results of Initial Operations in Non-Small Cell Lung Cancer Patients With Single-Level N2 Disease
Ohta et al.
Ann. Thorac. Surg. 2006;81:427-433.
ABSTRACT | FULL TEXT  

Nodal Involvement at the Time of Pulmonary Metastasectomy: Experiences in 245 Patients
Pfannschmidt et al.
Ann. Thorac. Surg. 2006;81:448-454.
ABSTRACT | FULL TEXT